Menopause

  • MyCelsius cooling bracelet makes TIME’s 2026 list

    The MyCelsius cooling bracelet, designed to ease hot flushes, has been named among TIME's Best Inventions of 2026, a year after its launch. The UK-developed wearable was one of two British inventions recognised in the Health & Wellness category. MyCelsius launched the bracelet in October 2025 and has since sold out its first production run. [...]

  • Fertifa agrees to acquire hormonal health specialist Tuune

    Fertifa has agreed to acquire women's health technology company Tuune, expanding its employee healthcare services into personalised hormonal care. Tuune develops regulated clinical software that assesses more than 70 symptoms alongside an individual's medical history to support clinical decisions about contraception and menopause. The deal continues Fertifa's expansion beyond its original focus on fertility benefits. [...]

  • Ennogen agrees $220m deal for Aspen’s European women’s health business

    Aspen Pharmacare has completed the €197m sale of Ovestin's European rights to privately owned Ennogen Healthcare International. Aspen received the payment on 3 November after Ennogen secured unconditional funding for the acquisition. Ennogen will also pay €4m for existing stocks of the product. Aspen will retain a manufacturing and supply role under a separate 10-year [...]

  • Spain to introduce paid sick leave for severe menopause-related symptoms

    Women living and working in Spain will be eligible for paid menopause sick leave from 1 December 2026 if a doctor confirms a related condition prevents them from working. The reform will provide specific medical leave for women experiencing incapacitating health problems associated with menopause. Eligible workers will receive Social Security benefits from the second [...]

  • Cinven agrees to buy women’s health company Theramex for €2.6bn

    Women's health pharmaceutical company Theramex is set to be acquired in a deal reportedly worth €2.6bn, with completion expected in the first half of 2027. The London-headquartered business provides treatments for menopause, osteoporosis, contraception, uterine health and fertility. The transaction remains subject to regulatory approval. Financial terms have not been formally disclosed. Theramex operates in [...]

  • Review finds no evidence that testosterone improves brain fog during menopause

    A review of five studies has found insufficient evidence that testosterone treatment improves memory and thinking in women during or after menopause. The combined analysis of three randomised controlled trials involving 244 women found no statistically significant improvement in cognitive function among those receiving testosterone compared with a placebo. Researchers stressed that the findings reflect [...]

  • Autistic women experience more severe menopausal symptoms – study

    Autistic women consistently experience more severe menopausal symptoms than non-autistic people, leading to poorer wellbeing and quality of life, new research has revealed/ They also reported higher levels of anxiety and depression and poorer quality of life, all of which were linked to the severity of their menopause symptoms. The study identified further differences in [...]

  • Perimenopause linked to higher risk of anxiety than other menopause stages – study

    Women in perimenopause had higher odds of reporting anxiety symptoms than women before or after menopause, a review of 21 studies involving 24,523 women found. Compared with premenopausal women, those in perimenopause had 59 per cent higher odds of reporting anxiety symptoms, while postmenopausal women had 63 per cent higher odds. However, a direct comparison [...]

  • Employers don’t know how to deal with menopause concerns, survey reveals

    Four in 10 employers lack clear procedures for supporting staff experiencing menopause, despite growing openness about the issue, a recent employee survey has revealed. A survey of HR professionals found that 42 per cent reported no clear approach to workplace menopause concerns, while just 5 per cent felt menopause-related concerns or complaints were handled consistently [...]

  • ADHD meds show menopause brain fog promise

    ADHD medications may improve self-reported menopause brain fog, new research suggests. The findings suggest that medicines used to treat ADHD could help women experiencing difficulties with concentration, memory and organisation during the menopause transition. However, the evidence is preliminary. Researchers say larger studies are needed to establish whether these medications are safe and effective for [...]